Hazard description
Siemens Healthineers has confirmed, through the investigation of customer complaints, the potential for the following issues associated with processing Atellica CH Urine Albumin (UAlb) tests on Atellica CH and Atellica CI analyzers.• Falsely depressed Atellica CH Urea Nitrogen (UN_c) results• Falsely depressed Atellica CH Enzymatic Hemoglobin A1c (A1c_E) results• Increased rate of reaction cuvette QC failuresThese issues may impact quality control (QC), calibrators, and patient results for the UN_c and A1c_E assays across all sample types.